Congressional Critics Offer Two Approaches To Drug Safety Responsibility
This article was originally published in The Tan Sheet
Executive Summary
Influential committee chairmen in the House and Senate are taking different tacks as they look at improving drug safety enforcement
You may also be interested in...
FDA Commissioner Must Not Come From Agency, Stupak Advises Obama
Rep. Bart Stupak has called on the incoming administration to look outside FDA for the next commissioner - even to fill the post short-term on an acting basis
FDA Commissioner Must Not Come From Agency, Stupak Advises Obama
Rep. Bart Stupak has called on the incoming administration to look outside FDA for the next commissioner - even to fill the post short-term on an acting basis
FDA Commissioner Must Not Come From Agency, Stupak Advises Obama
Rep. Bart Stupak has called on the incoming administration to look outside FDA for the next commissioner - even to fill the post short-term on an acting basis